ACTIVE

APOTHEEK MANN

Financial year 2025 · closed on 31/12/2025
Net result
147,7 k €
+87.8% YoY
Gross margin
392,4 k €
+34.8% YoY
Equity
358,4 k €
+8.4% YoY
Workforce
2,2 ETP
+22.2% YoY

What does APOTHEEK MANN do?

APOTHEEK MANN is a Private company with limited liability incorporated in 2009. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Antwerpen. It employs on average 2,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0815.855.617
Incorporation
26/06/2009
Legal form
Private company with limited liability
Registered office
Jan Van Rijswijcklaan 82
2018 Antwerpen · FlandreSee on map
Contributed capital
96 000,00 €
Latest accounts
31/12/2025
Average workforce
2,2 ETP
Joint committees (2)
  • 313
  • 31300
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 10 financial years

2025202420232022202120202019201220112010
Income statement
Gross margin392,4 k €291 k €259,3 k €231,6 k €191,2 k €157,3 k €196,3 k €171,4 k €281,2 k €368,2 k €
EBITDA251 k €177,7 k €171,8 k €113,5 k €85,8 k €58,5 k €95,6 k €96,1 k €169,6 k €230,3 k €
Operating result182,8 k €113,9 k €123,6 k €80,9 k €53,4 k €29,1 k €39 k €32 k €104,9 k €141,3 k €
Net result147,7 k €78,6 k €100,9 k €55,9 k €39 k €12,2 k €16,3 k €-8,3 k €48,8 k €48,2 k €
Balance sheet
Equity358,4 k €330,7 k €312,1 k €263,2 k €247,4 k €223,3 k €211,1 k €107,3 k €115,6 k €66,8 k €
Total assets1,1 M €1,2 M €1,2 M €959,3 k €911,5 k €749,3 k €755,6 k €622,6 k €774,6 k €757,7 k €
Cash19,6 k €6,3 k €10,3 k €28,4 k €31,5 k €16,4 k €10,8 k €10,2 k €47 k €30,3 k €
Debts723,8 k €821,4 k €874,9 k €696,1 k €664,1 k €525,9 k €544,5 k €515,3 k €659 k €689,5 k €
Other
Workforce2,2 ETP1,8 ETP1,5 ETP0,0 ETP1,7 ETP1,6 ETP1,2 ETP2,1 ETP1,3 ETP1,3 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

PHARMA COVA

Manager · since 01 janvier 2019 · 0826.853.833

Represented by Filip Cortebeeck

Active

Ended mandates

PHARMA COVA

Director · since 01 janvier 2019 · 0826.853.833

Represented by Cortebeeck FILIP

Ended
PHARMA COVA

Director · since 01 janvier 2019 · 0826.853.833

Represented by Filip Cortebeeck

Ended
PHARMA COVA

Manager · since 01 janvier 2019 · 0826.853.833

Represented by Filip Cortebeeck

Ended
Dirk Nauwelaers

Manager

Ended
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/07/202606/07/202529/08/202407/08/202330/08/202227/08/2021
General meeting29/06/202630/06/202530/06/202402/05/202302/05/202203/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

16 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/06/202630/07/2026DutchPDF
Abridged model31/12/202430/06/202506/07/2025DutchPDF
Abridged model31/12/202330/06/202429/08/2024DutchPDF
Abridged model31/12/202202/05/202307/08/2023DutchPDF
Abridged model31/12/202102/05/202230/08/2022DutchPDF
Abridged model31/12/202003/05/202127/08/2021DutchPDF
Abridged model31/12/201904/05/202007/12/2020DutchPDF
Abridged model31/12/201801/05/201906/08/2019DutchPDF
Abridged model31/12/201701/05/201806/07/2018DutchPDF
Abridged model31/12/201601/05/201730/08/2017DutchPDF
Abridged model31/12/201502/05/201626/08/2016DutchPDF
Abridged model31/12/201401/05/201528/08/2015DutchPDF
Abridged model31/12/201301/05/201425/08/2014DutchPDF
Abridged model31/12/201202/05/201319/08/2013DutchPDF
Abridged model31/12/201102/05/201208/06/2012DutchPDF
Abridged model31/12/201002/05/201131/05/2011DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

PHARMA COVA

Manager · since 01 janvier 2019 · 0826.853.833

Represented by Filip Cortebeeck

Active

Ended mandates

PHARMA COVA

Director · since 01 janvier 2019 · 0826.853.833

Represented by Cortebeeck FILIP

Ended
PHARMA COVA

Director · since 01 janvier 2019 · 0826.853.833

Represented by Filip Cortebeeck

Ended
PHARMA COVA

Manager · since 01 janvier 2019 · 0826.853.833

Represented by Filip Cortebeeck

Ended
Dirk Nauwelaers

Manager

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates14/02/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares13/12/2013
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Capital / shares17/06/2010
    KAPITAAL - AANDELEN - DIVERSEN
    PDF
  • Other08/07/2009
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025147,7 k €
  2. 2024
    Annual accounts 202478,6 k €
  3. 2023
    Annual accounts 2023100,9 k €
  4. 2022
    Annual accounts 202255,9 k €
  5. 2021
    Annual accounts 202139 k €
  6. 2020
    Annual accounts 202012,2 k €
  7. 2019
    Annual accounts 201916,3 k €
  8. 2012
    Annual accounts 2012-8,3 k €
  9. 2011
    Annual accounts 201148,8 k €
  10. 2010
    Annual accounts 201048,2 k €
  11. 26/06/2009
    IncorporationPrivate company with limited liability